measured contents of the hexoses in brain and plasma, the relationships of the tissue concentrations and distri bution spaces of each of the hexoses and of the A (i.e., ratio of tissue distribution space of DG to that of glucose) of the DG method to the tissue glucose concentration were derived. The A was then quantitatively related to the measured equilibrium ratio for [14Clmethylglucose over the full range of brain and plasma glucose levels. By com bining these new data with the values for the lumped constant, the factor that converts rate of DG phosphory lation to glucose phosphorylation, previously determined in rats over the same range of plasma glucose levels, the phosphorylation coefficient was calculated and the lumped constant graphed as a function of the measured distribution space in brain for [14Cjmethylglucose. Key Words: Cerebral glucose utilization-Hexose distribution spaces-Hyperglycemia-Hypoglycemia. steady-state brain/plasma distribution ratio of DG to that of glucose; <I> equals the fraction of glucose that, once phosphorylated, continues down the gly colytic and pentose phosphate shunt pathways; V� and V m are the maximal velocities and K� and Km are the Michaelis-Menten constants of hexokinase for DG and glucose, respectively. Because glucose-6-phosphate is negligibly dephosphorylated in brain (Dienel et al., 1988) , <I> equal � 1.0. Vi:,Km/V mK�, the phosphorylation coefficient (Sols and Crane, 1954) , is a property of the species of hexokinase and can be expected to remain constant in normal brain with time and condition (Thompson and Bachelard, 1970; Purich et ai., 1973; Sokoloff et ai., 1977; Wil-son, 1985) . On the other hand, A is dependent on the balances between delivery and transport of DG and glucose from blood to brain and their phosphoryla tion in the tissues. A can therefore be expected to change in conditions in which either of these bal ances is altered (Crane et aI., 198 1; Cunningham and Cremer, 198 1; Gjedde, 1982; Pardridge et aI., 1982a,b; Pardridge, 1983) . Chemical measurements of A in rat brain have, in fact, confirmed that it increases in hypoglycemia and decreases in hyper glycemia (Mori et aI., 1989) , and these changes are reflected in corresponding alterations in the value of the lumped constant (Schuier et aI., 198 1, 1990; Suda et aI., 198 1, 1990) .
It can be shown that A is a function only of tissue glucose content and the kinetic constants of the transport carrier and of hexokinase for DG and glu cose and that it varies with the glucose concentra tion in the tissue (Crane et aI., 198 1; Gjedde, 1982; Pardridge et aI., 1982a,b; Pardridge, 1983) . If tissue glucose content is known, then A and the lumped constant can be determined. Gjedde (1982) has pointed out that because 3-0-methyl-D-glucose (methylglucose) competes with glucose for blood brain barrier transport but is itself not metabolized, the equilibrium brain/plasma distribution ratio for me thylglucose is quantitatively related to the steady state distribution ratio for glucose. Gjedde and as sociates (Gjedde, 1982; Diemer and Gjedde, 1983; Gjedde and Diemer, 1983; Gjedde et aI., 1985; Ne dergaard et aI., 1986 Ne dergaard et aI., , 1988 have exploited this re lationship and used radioactive methylglucose to determine the glucose contents, A, and lumped constants in local regions of the brains of animals and humans. Their approach is, however, critically dependent on the accuracy of their model and pre cise knowledge of the values for the kinetic con stants for transport and phosphorylation of glucose and DG.
Our laboratory has approached the problem em pirically. We have controlled the brain glucose con tent over a wide range by clamping plasma glucose concentrations at various levels ranging from hypo glycemia to hyperglycemia and determined the cor responding lumped constants by the model-inde pendent, steady-state method (Schuier et aI., 198 1, 1990; Suda et aI., 198 1, 1990) and the values for A by direct chemical measurements (Mori et aI., 1989) . In the present study we have also measured the equilibrium brain/plasma distribution ratio for e4C] methylglucose. In the course of these studies, we found acid-labile products of e4C]DG in the brain that degraded to e4C]DG and artifactually raised the values for the e4C]DG space and for A when the brain was extracted with the commonly used per-chloric acid extraction procedure; this effect was particularly prominent in hypoglycemia (Dienel et aI., 1990) . Accordingly, we have redetermined the values for A at the various plasma and brain glucose concentrations in brains extracted with ethanol, which avoids this artifact. t-butanol/water (15:30:40: 15, vol/vol/vol/vol) as the sol vent (Vomhof and Tucker, 1965 ) and found to be -98%. Hexokinase (EC 2.7.1.1) and yeast glucose-6-phosphate dehydrogenase (EC 1.1.1.49) were obtained from Boeh ringer-Mannheim (Indianapolis, IN, U.S.A.). D-Glucose was purchased from Sigma (St. Louis, MO, U.S.A.). Dowex-l-formate (AGI-X8, 100-200 mesh) ion exchange resin was obtained from Bio-Rad (Richmond, CA, U.S.A.).
MATERIALS AND METHODS

Chemicals
Animals
Normal male Sprague-Dawley rats weighing 250-350 g were obtained from Taconic Farms (Germantown, NY, U.S.A.) and maintained on laboratory chow and water ad libitum. They were deprived of food -12 h prior to initi ation of the experiments to help stabilize their plasma glucose levels during the procedure. Under 1 % halothane/ 70% N20 anesthesia, polyethylene catheters were in serted into one femoral artery and both femoral veins, and then at least 2 h was allowed for recovery. The rats were kept in fenestrated acrylic cages throughout the re mainder of the experimental procedure (see below).
Physiological variables
Body temperature was monitored with a rectal therm istor connected to an indicating controller (YSI model 73A; Yellow Springs Instrument Co., Yellow Springs, OH, U.S.A.) and maintained at 37°C by a thermostati cally controlled heating lamp. Mean arterial blood pres sure was measured with an air-damped Hg manometer. Arterial blood pH, P02, and Pe02 were measured with a Corning model 158 pH/Blood Gas Analyzer (Corning Medical and Scientific, Medfield, MA, U.S.A.). Arterial blood pressure, blood gases, and hematocrit were mea sured just before infusion of tracer and just before killing. The physiological variables in all rats induded in this study were within normal limits for this laboratory and similar to those reported previously (Mori et aI., 1989) . The steady-state brain/plasma distribution ratios for e4C]DG, glucose, and [14C]methylglucose were deter mined over a wide range of arterial plasma glucose levels. Arterial plasma glucose concentrations in normal con-scious rats were clamped at levels from 2 to 28 mM by programmed infusions of n-glucose supplemented by in sulin when needed as described by Mori et ai. (1989) . After the plasma glucose level had been clamped at the desired level for 30-40 min, the [14Clmethylglucose level in the arterial plasma was also clamped for �45 min by means of a programmed intravenous infusion of e4Cl methylglucose (50 /-LCi in total volume of 1.5 ml) while the glucose clamp was still maintained. The [14Clmethylglu cose infusion schedules were determined by the method of Patlak and Pettigrew (1976) and implemented as de scribed for [14C1DG by Mori et ai. (1989) .
While the glucose and [14Clmethylglucose clamps were maintained, arterial samples were drawn every 5 min for assay of glucose and [14Clmethylglucose concentrations to verify their constancy. About 45 min after onset of the e4Clmethylglucose infusion, the rats were anesthetized lightly with intravenous sodium thiopental « 15 mg/kg) and immediately placed in the freeze-blowing apparatus (Veech et aI., 1973) . (The brain freeze-blowing apparatus was constructed by and is available on order from Mr. James Reece, Research Resources Branch, National In stitute of Mental Health, Bldg. 36, Rm. 2A-03, Bethesda, MD 20892, U.S.A.). The thiopental served to minimize hyperglycemic effects of stress associated with this posi tioning (Wong and Tyce, 1978) . Arterial samples were immediately drawn for measurement of hematocrit, pH, Peo2, Po2, and plasma [14Clmethylglucose and glucose contents, and the rats were killed by almost instantaneous removal of their brains by freeze-blowing within 2 min after the injection of thiopental. The frozen brain and last two plasma samples were stored at -80°C until extracted with ethanol and assayed for hexose contents as de scribed below. The other timed arterial blood samples were centrifuged immediately, their plasma glucose con centrations were measured by the glucose oxidase method in a Beckman Glucose Analyzer II (Beckman In struments, Fullerton, CA, U.S.A.), and their plasma [14Clmethylglucose concentrations were measured by liq uid scintillation counting of the 14C (Beckman model LS 5801) with external or internal standardization with cali brated e4Cltoluene. Rats were excluded from the study if the concentration of either glucose or e4Cjmethylglucose in the arterial plasma deviated from the desired constant level by more than ± 10% during the experimental period.
Determination of glucose, DG, and methyl glucose concentrations, brain/plasma distribution ratios, and A Distribution spaces for DG and glucose were deter mined from measurements of their concentrations in brain and plasma obtained in our previous study (Mori et aI., 1989 ) and stored at -80°C, but extracted with alcohol in the present study. The glucose and [14C1DG contents were found to be stable with such storage.
Tissue extraction. Measured portions of frozen brain powders and plasma samples were extracted with etha nol/phosphate-buffered saline/water (65: 10:25, vol/ voUvol) by a modification of the procedure of Schmidt et al. (1974) . The saline solution consisted of 8 g NaCl, 0.2 g KCl, 1.15 g Na2HP0 4 , and 0.2 g KH2P0 4 dissolved in 800 ml water. Two milliliters of ice-cold extraction medium was added to the frozen brain samples (100-200 mg) in a tube kept on dry ice. The tube was then transferred to an alcohol bath maintained at -8 to -10°C, and the slurry was mixed by gentle vortexing until the ethanol solution penetrated the tissue powder. Lumps of powder were dis persed with a glass rod, and the slurry was periodically mixed for � 15 min at 4°C. The suspension was centri fuged at 4°C at 6,000 g for 30 min, the soluble fraction was transferred to another tube, and the pellet was resus pended by stirring with a glass rod and reextracted as above three more times. The combined supernatant frac tions were lyophilized in a SpeedVac Concentrator (Sa vant Instruments, Farmingdale, NY, U.S.A.); each sam ple was removed from the concentrator as soon as dry and dissolved in 1-2 ml of ice-cold water because of ev idence that warming of samples in the dry state could cause derivatization of hexoses. The resulting turbid so lutions were centrifuged at 31,000 g for 60 min at 4°C, and the supernatant fractions were quickly frozen and stored at -80°C until assayed for glucose and e4C1DG or [14Clmethylglucose concentrations.
Assay of glucose, [14CjDG, and t4Cjmethylglucose concentrations. Glucose contents of the ethanol extracts were measured with hexokinase and glucose-6-phosphate dehydrogenase (Lowry and Passonneau, 1972) . In our earlier determinations of A. (Mori et aI., 1989) , all the 14C in plasma and in the nonacidic fractions (i.e., effluents from Dowex-l-formate columns used to remove the acidic 14C-labeled metabolites) isolated from brain ex tracts was assumed to be in [14C1DG. We have recently found, however, some of the 14C in the non acidic frac tions from plasma and brain is in nonphosphorylatable metabolites of [14C1DG, and these are particularly prom inent in hypoglycemia (Dienel et aI., 1990 ). In the pres ent studies, therefore, only the 14C of the nonacidic frac tions of plasma and tissue extracts contained in compounds that could be phosphorylated by hexokinase was consid ered to represent [14C1DG. The [14C1DG contents of brain and plasma were assayed as follows. Portions of plasma or of ethanol extracts of brain were incubated at room temperature for 1-2 h with 50 mM Tris (pH 8.3), 18 mM MgCI2, 9 mM ATP, and 4 units (SI) of hexokinase to derivatize [14C1DG to [14C1DG-6-P. Portions (0.5 mt) of these mixtures before and after incubation were paired and applied to Dowex-l-formate columns (0.8 x 5 cm). The columns were washed with 23 ml of water and then eluted with 23 ml of 2 M HCtl2 M NaCI. Samples of the effluents and eluates were assayed for their 14C contents by liquid scintillation counting. The Dowex-l-formate ef fluents from the samples that had not been incubated (i.e., not derivatized with ATP and hexokinase) contained all the 14C in nonacidic compounds, including e4C1DG; the effluents from the incubated samples in which [14C1DG had been derivatized to [14C]DG-6-P contained the nonphosphorylatable, 14C-Iabeled, non acidic metab olites of [14C1DG. The [14C1DG concentration of each sample was then calculated by subtracting the nonphos phorylatable 14C from the total 14C in these nonacidic fractions.
[14C1Methylglucose is not significantly converted to la beled products in rat brain or plasma (Jay et aI., 1990) , and the 14C contents in nonacidic fractions (Dowex I-formate effluents) of acid extracts of brain agreed to within ±5% with those derived from ethanol extracts of the same brains. [14C1Methylglucose contents of plasma and brain were therefore assayed by liquid scintillation counting of whole plasma and ethanol extracts of brain.
Correction of total brain hexose concentrations for hexose contents of blood in brain. When their arterial concentrations are maintained constant, the hexose con tents of the blood contained in the brain at the time of killing may contribute significantly to their concentra tions measured in freeze-blown brains. This contribution is especially prominent in hypoglycemia when glucose or [14C]DG levels in brain tissue fall to very low levels. Mea sured contents of glucose, [14C]DG, and [14C]methyl glucose in brain were therefore corrected for the amounts contributed by the blood according to the following equa tion:
where Ci equals the calculated concentration of the hex ose in the brain tissue itself, CT is the measured hexose concentration in freeze-blown brain tissue, Cll is the hex ose concentration in whole blood at the time of killing, and WB/WT is the fraction of total brain mass contributed by the blood in the tissue. WB/WT was not measured; the value of 2.6% determined by Veech et al. (1973) for freeze-blown rat brain was used. CB was calculated by multiplying the measured arterial plasma concentrations at the time of killing by 0. 67 for glucose and e4C]DG and 0.75 for [14C]methylglucose (i. e. , steady-state whole blood/plasma ratios measured for each hexose in whole blood and corresponding plasma sample).
Calculation of hexose distribution spaces and A. The two concentrations of glucose, e4C]DG, and e4C]methyl glucose measured in arterial plasma immediately before and after positioning of the rat in the fr eeze-blowing ap paratus were averaged. The distribution spaces for each of the hexoses in brain were calculated by dividing the tissue concentration of the hexose (corrected for the con tribution of the blood) by this averaged plasma concen tration. A was calculated by dividing the distribution space for e4C]DG by that for glucose (Sokoloff et aI. , 1977) .
RESULTS
Influence of arterial plasma glucose level on concentrations of hexoses and labeled metabolites in plasma
There were nonacidic, nonphosphorylatable, 14C_ labeled metabolites of [14C]DG in the arterial plasma, but their amounts varied little with the plasma glucose level and were essentially the same 45 min after onset of the programmed e4C]DG in fusion over the entire range of plasma glucose con centrations examined. Because the infusion sched ules were designed only to maintain plasma e4C] DG levels constant with time but not at any specific level, steady-state e4C]DG levels in plasma did vary with plasma glucose concentration; e4C]DG levels in plasma were maximal with plasma glucose levels of 8-12 mM and fell with plasma glucose levels above or below that range. The metabolites, therefore, accounted for variable proportions of the total 14 C in plasma, ranging from a minimum of J Cereb Blood Flow Metab, Vol. II, No. I, 1991 -10% in normoglycemia to -30% in hypoglycemia (data not shown).
Influence of arterial plasma glucose level on concentrations of hexoses and labeled metabolites in brain
Measured concentrations of glucose, e4C]DG, and e4C]methylglucose in whole brain were cor rected for the amounts contributed by the blood in the brain (Fig. 1) . This correction was much more critical to the glucose than [ 14 C]DG and e4C]meth ylglucose determinations because of the lower brain/blood distribution ratio for glucose. It was very large in hypoglycemia during which brain glu cose contents (see Fig. 1 of Holden et aI., 199 1) and steady-state brain/plasma distribution ratios (Fig. 2) fell with increasing severity of hypoglycemia. When plasma glucose levels exceeded 6 mM, the correc tion was only -5-10%, but rose progressively with decreasing plasma glucose concentrations to �80% at 2 mM (Fig. lA) . On the other hand, the correc tions for the contributions of the blood to the [14C]DG ( Fig. lB) and [14C]methylglucose (data not shown) concentrations were quite small at all plasma glucose levels because of their compara tively high tissue/plasma distribution ratios (Fig. 2) .
Brain glucose contents, corrected for contribu tions from blood, fell nearly proportionately with Assumed 2.6% blood in freeze-blown brain (Veech et ai., 1973) . -. : -
Assumed 2.6% blood in freeze-blown brain .: . , declining plasma glucose levels between 28 and 3-4 mM and then stabilized between 0.05 and 0. 15 j..L mollg when plasma glucose levels were below 3 mM (see Fig. 1 of Holden et aI., 199 1). In contrast, brain ['4C]DG content rose progressively to a max imum as plasma glucose levels fell from hypergly cemia (28 mM) to normoglycemia (7-12 mM), but then reversed and declined with increasing depth of hypoglycemia (data not shown). Nonacidic, nonphosphorylatable, 14C-Iabeled metabolites of [14C]DG, which separated with ['4C]DG on Dowex-l-formate chromatography, were found in all the brains at the end of the 45-min programmed infusion (data not shown), but their amounts were small and unrelated to plasma glu cose levels as long as these levels were above 5 mM. The amounts of these metabolites, however, increased severalfold when plasma glucose levels fell to 2-3 mM. Their contribution to the total 14 C in the nonacidic fractions isolated from brain was be low 7% in hyperglycemia and normoglycemia but rose to as much as 30% in severe hypoglycemia.
Influence of glucose concentrations in arterial plasma and brain on the steady-state brain/plasma distribution ratios for the hexoses The steady-state brain/plasma distribution ratio (i.e., distribution space) was smallest for glucose, intermediate for [14C]DG, and highest for [,4C]meth ylglucose at all plasma (see Fig. 2 for Holden et aI., 199 1) and brain (Fig. 2) glucose levels. These dis tribution spaces varied with the glucose concentra tions in arterial plasma and brain. The patterns of variation in the glucose and [14C]DG spaces were similar but not identical. With glucose concentra tions above 9 mM in plasma or 1.5 flmollg in brain (Fig. 2) , the values for the glucose distribution space were quite stable (mean ± SD, 0.20 ± 0.02 mllg, n = 13) and were not statistically significantly correlated with the plasma glucose level (r = -0.26, p = 0.38). On the other hand, the values for the [14C]DG space showed a moderate though pro gressive and statistically significant (r = -0.83, p < 0.00 1) decrease with increasing plasma glucose levels above 9 mM. Below glucose levels of 1.5 flmol/g in brain (Fig. 2) , the distribution spaces for both glucose and [14C]DG fell steeply with decreas ing glucose concentrations. In contrast, the ['4C] methylglucose distribution space decreased pro gressively as plasma and brain glucose levels rose from hypoglycemia to hyperglycemia levels (Fig.  2) . The results are similar to those obtained by Bus chiazzo et ai. (1970) .
Influence of arterial plasma and tissue glucose concentrations on A and phosphorylation coefficient
Values for A (Fig. 3) at the various plasma and brain glucose levels were calculated from the steady-state plasma and brain concentrations of the hexoses (Fig. 2) . The results confirmed our earlier finding (Mori et aI., 1989 ) that A is relatively stable with plasma and brain glucose at normoglycemic and hyperglycemic levels but increases sharply as glucose concentrations fall below 4 mM in plasma (Fig. 3A) or 0.5 flmollg in brain (Fig. 3B) . Values for A varied widely (e .g., from � 5 to 14) as glucose concentrations fell from 3 to 2 mM in plasma (Fig.  3A) or 0. 15 to 0.05 flmol/g in brain (Fig. 3B) . Some of this variation may have arisen from inaccuracies in the determination of the very low glucose con tents in hypoglycemic rat brains. Correction for glu cose in the blood in brain is critical at this level of FIG. 3. Influence of arterial plasma glucose level (A) and brain glucose concentration (8) on A, the ratio of the steady state distribution ratio of 2-C4C]deoxyglucose between brain and plasma to that of glucose. hypoglycemia (Fig. IA) , and small errors in the es timation of the blood content of freeze-blown brains could cause large errors in the determination of brain glucose contents and, therefore, also of A. The phosphorylation coefficient is the ratio of the Michaelis-Menten constants of hexokinase for e4C]DG and glucose and can be expected to be independent of plasma and brain glucose levels. It was calculated in the present study by dividing the lumped constant by the A at the equivalent plasma glucose concentration; <I> was assumed to be equal to 1.0. The values for the lumped constant were those previously measured in this laboratory by the steady-state method over a range of plasma glucose concentrations from hypoglycemia to hyperglyce mia (Schuier et aI., 1990; Suda et aI., 1990) . The J Cereb Blood Flow Me/ab, Vol. 11, No.1, 1991 values of A were determined in the present study (Fig. 3A) . The phosphorylation coefficient thus cal culated did not correlate significantly with arterial plasma glucose level in the range between 6 and 27 mM (p > 0. 1). The phosphorylation coefficient over this range was 0.22 ± 0.03 (mean ± SD, n = 15; Fig. 4) . In hypoglycemic rats with plasma glucose levels declining below 6 mM, the phosphorylation coefficient tended to decrease progressively. This downward trend in the value of the phosphor ylation coefficient in hypoglycemia is more appar ent than real. It almost certainly arose from over estimations of A because of progressively greater overcorrection for the contribution by the blood to the tissue content with decreasing plasma glucose levels. In normoglycemia and hypoglycemia, in which the extraction fraction of glucose from the blood traversing the brain is small, the use of pe ripheral blood to estimate the glucose content of the blood in the brain is reasonable. In hypoglycemia, however, the extraction fraction becomes much greater, and the glucose in the blood in the brain falls below that of peripheral blood, which was used in the corrections. It is likely, therefore, that the value of 0.22 determined in normoglycemia and hy perglycemia is the most valid estimate of the phos phorylation coefficient.
Relationships of A and lumped constant to steady-state brain/plasma distribution ratio for methylglucose
The equilibrium brain/plasma distribution ratio for [14C]methylglucose and the value for A varied with brain glucose concentration; both increased progressively more steeply with decreasing brain glucose concentration (Fig. 5A ). If the methylglu cose distribution ratio is known, then the brain glu cose concentration and the corresponding value for A can be estimated from the curves in Fig. 5A and B, respectively. The curve in Fig. 5B relating the methylglucose distribution ratio to A was drawn from paired values for A and the methylglucose dis tribution ratio taken at various levels of brain glu cose concentration from the smooth curves in Fig. SA. If the phosphorylation coefficient is also known and assumed to be constant, i.e., 0.22 (Fig. 4 ) at all brain glucose levels, then the lumped constant (i.e., A x 0.22) at any brain glucose concentration can also be determined from the relationship illustrated by the curve in Fig. SB . For convenience of use, the relationship between the lumped constant and the distribution space for methylglucose is tabu lated in Table 1 .
DISCUSSION
The present study provides experimentally deter mined, model-independent values for the distribu tion spaces of glucose and DG in brain and for the A of the lumped constant at various concentrations of glucose in plasma and brain ranging from hypogly cemia to hyperglycemia. The A varies with the tis- sue glucose concentration and can be determined if the glucose concentration in the brain tissue is known (Crane et aI., 198 1; Gjedde, 1982; Pardridge et aI., 1982a,b; Pardridge, 1983 ). Gjedde and asso ciates (Gjedde, 1982; Diemer and Gjedde, 1983; Gjedde and Diemer, 1983; Gjedde et aI., 1985; Ne dergaard et aI., 1986 Ne dergaard et aI., , 1988 have proposed the use of 3-0-methylglucose to determine glucose concen trations in brain. Because 3-0-methylglucose com petes with glucose for blood-brain barrier transport but is not metabolized in brain, its equilibrium brain/plasma distribution ratio is a reflection of the brain/plasma glucose distribution ratio or the glu cose concentration in the brain. We, therefore, also measured the distribution spaces for methylglucose in brain over the same range of plasma and brain glucose concentrations to determine by direct chemical measurements the relationships of the brain methylglucose distribution space to both the brain glucose content and the A. From the present values of A and the values of the lumped constant, also measured by direct model-independent meth ods (Schuier et aI., 1990; Suda et aI., 1990) , the phosphorylation coefficient in vivo could be evalu ated (Fig. 4) , and the value of the lumped constant could be related to the methylglucose distribution ratio at all of the levels of brain glucose within the range studied ( Fig. 5 ; Table I) . It therefore becomes possible to determine the lumped constant from the equilibrium brain/plasma distribution ratio for meth ylglucose on the basis of directly measured data rather than on the results of model-dependent, least-squares best fits. The data in Fig. 5B and Table I can be used to determine local values for A and the lumped con stant in brain from the local equilibrium brain/ plasma distribution ratios for methylglucose, re spectively. These local distribution ratios can be measured autoradiographically with radioactive methylglucose. In cases in which there are local pathological changes that are not spatially repro ducible, it is desirable to determine the local lumped constants simultaneously with the local rates of ce rebral glucose utilization. This could be done with 3H_ and 14 C-Iabeled methylglucose and DG and double-label autoradiography, as, in fact, Gjedde and associates Gjedde J Cereb Blood Flow Metab, Vol. 11, No.1, 1991 and Nedergaard et aI., 1986 Nedergaard et aI., , 1988 have done. We are currently developing for this purpose a suitable double-label autoradiographic technique that corrects fully for the differential self absorption of the 3H radiation in the brain sections and is quantitatively accurate.
The values of A and the lumped constant change whenever the balance between glucose supply and demand is changed, resulting in an alteration in tis sue glucose concentration. Their relationships to the brain/plasma distribution ratio for methylglu cose determined in the present study apply to changes in tissue glucose content produced by al tering the supply of glucose to the brain. There are theoretical reasons to suspect that the distribution ratio for methylglucose might fall rather than rise with decreasing tissue glucose content due to in creased metabolic demand in the presence of sus tained normally adequate supply of glucose. If so, then the relationships defined by the present study would not apply. Studies are currently in progress to examine these relationships during enhanced metabolic demand, as, for example, that seen dur ing convulsive activity. These relationships would also be expected to change if the species or isoen zyme of hexokinase were to change, as, for exam ple, in tumors (Kapoor et aI., 1989) .
This study also illustrates the usefulness of ap propriate interplay of direct measurements and model fitting in the analysis of physiological and biochemical processes in vivo. We first attempted to fit a model of the processes in brain to our pre vious experimental data on the relationships be tween A and brain and plasma glucose concentra tions (Mori et aI., 1989) . The model was unable, however, to predict the very high values for the DG distribution space and A in hypoglycemia. Either the model was wrong, or the measurements of the precursor pool of DG in brain were in error, or both. The discrepancy suggested that the DG con centrations measured in brain might have included DG from pools other than the precursor pool for phosphorylation and back-transport from tissue to plasma. In searching for possible sources of DG in the tissue other than the precursor pool, we found that perchloric acid extraction of brain, a commonly used procedure, degraded acidic metabolites of DG-6-P (e.g., DG-l-phosphate and uri dine diphospho DG) back to free DG, which was then included in the assayed DG (Dienel et aI., 1990) . The analyses were therefore repeated, this time with ethanol ex traction of the tissues, which does not cause such degradations (Dienel et aI., 1990) . More extensive chemical analyses also revealed the presence of nonacidic, nonphosphorylatable, 14 C-Iabeled me-tabolites of e4C]DG that had also been previously assayed as e4C]DG. The magnitude of the contam ination with these acid-labile and nonphosphorylat able products of e4C]DG was small in normoglyce mia and hyperglycemia, but markedly increased in hypoglycemia, probably because of the disinhibi tion of e4C]DG uptake and metabolism in the pres ence of low levels of glucose in plasma and brain. It was also found that brain glucose levels fell so low in hypoglycemia that even though the glucose con tent of the blood was markedly decreased, it was still sufficient to lead to large overestimation of the glucose contents of the brain tissue itself. These methodological problems have been taken into ac count in the present studies, and the model dependent fits now agree quite well with the mea sured data (Holden et al., 199 1) . It should be noted that all the conclusions from the present study are based on measured data obtained from experiments suggested by the modeling and not on the results of modeling per se.
These methodological problems, especially the regeneration of free DG during acid extraction of the tissues, must also have led to overestimation of the precursor DG pool and underestimation of the product pool in numerous studies of the kinetics of interconversion of e4C]DG and [14C1DG-6-P in brain (Hawkins and Miller, 1978; Miller and Kiney, 198 1; Huang and Veech, 1985; Jenkins et al., 1986; Nelson et al., 1986; Bass et al., 1987; Pelligrino et al., 1987; Newman et at., 1988a, b; Mori et at., 1989) . Such errors in the determinations of these pools would exaggerate the apparent loss of prod ucts of DG metabolism and lead to overestimates of k.4', the rate constant for loss of DG-6-P assumed to be due to glucose-6-phosphatase. These estimates would have included the loss of product in the test tubes during the analyses along with any loss that might have occurred in the brains of the animals in vivo.
